3rd Allogeneic Cell Therapies Summit Europe

A year on from the first European allogenic approval, join 60+ industry experts as they discuss the current landscape and promising emerging pipelines at the 3rd Allogeneic Cell Therapies Summit Europe!

Hear expert insights from Caribou Biosciences, Cellectis, AdaptImmune and many more as they share their recent breakthroughs and strategies to overcome challenges such as alloreactivity, durability, and upscaling their therapies.

As Europe’s only conference purely focused on allogeneic research, this is the only opportunity for you to network with other industry leaders, solve shared challenges and have your burning questions answered by leading experts.

Time: 9:00 AM – 3:15 PM

Venue details: Hilton London Olympia, 380 Kensington High Street, London, England, W14 8NL, United Kingdom

Prices: GBP 2049.00 – GBP 4047.00

Speakers: Anastasios Karadimitris, Co-Director Centre for Haematology, Professor of Haematology Karadimitris Lab, Imperial College London, Augustin de Bettignies, Chief Business Officer, MPC therapeutics, and more